Farms.com Home   News

Innovacyn Introduces New Vetericyn Plus For Dairy, Beef Cattle

Innovacyn, a leader in innovative medical devices in the human and animal health industry, announced a new and improved formulation in their animal line of healthcare products-Vetericyn Plus, available for dairy and beef cattle.

Vetericyn Plus is a product line of innovative solutions indicated for wounds, pink eye, udder ailments and teat irritations. Uniquely formulated, the technology platform offers a non-toxic and antibiotic free solution that is highly effective in dermal cleaning and debriding, allowing for optimal healing conditions.

The new formulation includes a higher concentration of hypochlorous making it up to three times as concentrated as original Vetericyn without requiring any withdrawal period.

Scott Van Winkle, Director of Animal Health Marketing at Innovacyn stated: "This is the product the dairy and beef cattle industry has been looking for.

Because it contains no antibiotics, it is safe to use and will not be harmful to milk production or beef. Our technology platform is evidence based and revolutionary for livestock production."

In response to market demand, Innovacyn recently built a new, state-of-the-art ISO certified manufacturing facility with a current production capacity of four million bottles of Vetericyn Plus a month and the ability to expand further. Vetericyn Plus and Vetericyn VF Plus are available for over-the-counter and veterinary markets, respectively.
 

Click here to see more...

Trending Video

Revolutionizing Pork Production: Gene Editing and Antimicrobial Stewardship with Banks Baker of PIC

Video: Revolutionizing Pork Production: Gene Editing and Antimicrobial Stewardship with Banks Baker of PIC

In this episode, we explore the transformative advancements in pork production with Banks Baker of PIC. Consumer expectations for high animal care standards, antimicrobial stewardship, and sustainable practices are reshaping the food industry. Innovative solutions and technologies are emerging to meet these demands, fostering sustainable food production.

Gene editing plays a pivotal role in enhancing animal health and aligns with antibiotic stewardship goals in pork production. Baker discusses the potential impact of gene editing on preventing diseases like PRRS and how it parallels successful applications in human healthcare. Challenges and considerations in applying this technology to animal agriculture, particularly in protecting pigs from diseases, are also explored.

PIC's groundbreaking development of a PRRS-resistant pig through gene editing is highlighted, offering broader implications for pig herd health and the significant reduction of antibiotic use. Navigating global regulatory systems presents challenges and opportunities for PIC, and Baker sheds light on the company's approach to gaining approvals worldwide.

Join us in this episode as we delve into the future of pork production, where cutting-edge technologies and sustainable practices are reshaping the industry landscape.